Rewind Therapeutics' Series A Round

Rewind Therapeutics raised a round of funding on January 04, 2018.

Rewind Therapeutics, founded by CD3 and Axxam, is developing novel re-myelinating therapies for patients suffering from Multiple Sclerosis and other myelin-related diseases.…

Articles about Rewind Therapeutics' Series A Round: